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1. Introduction
  Asthma is a chronic inflammatory disease of the lung 
characterized by episodic airway obstruction and increased 
bronchial responsiveness[1]; the structural features include 
epithelial shedding, increased airway smooth muscle 
mass, mucus gland hyperplasia, sub epithelial fibrosis and 
infiltration of the bronchial wall whit inflammatory cells[2]. 
Bronchial obstruction is the most important symptom 
because of the potential risk of severe asthma attacks; 
however, other non-obstructive symptoms are frequent and 
may also cause severe suffering and poor quality of life[3]. 
The current treatment does not resolve the disease and 
only focuses on countering episodes of bronchospasm and 
controlling the underlying inflammation[4]. Together, the 
high level tolerance and resistance of asthmatic patients, 
as a result of frequent drug use, increase the interest and 
Objective: To assess the relaxant effect of several organic extracts obtained from Agastache 
mexicana (A. mexicana), Cochlospermum vitifolium (C. vitifolium), Cordia morelosana (C. 
morelosana), Lepechinia caulescens (L. caulescens) and Talauma mexicana (T. mexicana) used 
in Mexican traditional medicine for the treatment of several diseases. Methods: Extracts were 
obtained by maceration at room temperature using hexane, dichloromethane and methanol for 
each plant material. The organic extracts were evaluated ex vivo to determine their relaxant 
activity on the contractions induced by carbachol (cholinergic receptor agonist, 1 毺mol/L) in isolated 
rat tracheal rings. Results: A total of 15 extracts were evaluated (three for each species). All test samples 
showed significant relaxant effect, in a concentration-dependent manner, on the contractions induced 
by 1 毺mol/L carbachol, with exception of extracts from C. morelosana. Active extracts were less 
potent than theophylline [phosphodiesterase inhibitor, EC50: (28.79±0.82) 毺g/mL] that was used as 
positive control. Concentration-response curves revealed that the extracts with more significant 
effects were dichloromethanic extracts of T. mexicana [Emax: (103.03±3.32)% and EC50: (159.39±3.72) 毺g/mL) 
and C. vitifolium [Emax: (106.58±2.42)% and EC50: (219.54±7.61) 毺g/mL]. Finally, hexanic and 
dichloromethanic extracts from A. mexicana were fully effective but less potent than T. mexicana 
and C. vitifolium. Conclusions: Less polar extracts obtained from A. mexicana, T. mexicana and 
C. vitifolium exhibited greater relaxant effect on tracheal rat rings, which allows us to suggest 
them as sources for the isolation of bioactive molecules with potential therapeutic value in the 
treatment of asthma.
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need to develop new therapeutic strategies with specific, 
unexplored targets acting on the mechanisms that generate 
the asthmatic episode.
  Mexico has over 4 000 species of medicinal plants, that have 
been used empirically by 80% of the indigenous population 
to treat health problems like respiratory diseases[5]. 
Current research was carried out in order to screen the 
pharmacological properties of Agastache mexicana (A. 
mexicana), Cochlospermum vitifolium (C. vitifolium), Cordia 
morelosana (C. morelosana), Lepechinia caulescens (L. 
caulescens) and Talauma mexicana (T. mexicana) to find 
candidates for further bio-guided studies, which allows the 
discovery of novel molecules with therapeutic properties 
for treating asthma, in particular, those which involve a 
contractile process of the smooth muscle cells.
2. Materials and methods
2.1. Chemicals and drugs
  C a r b a m y l c h o l i n e  ( c a r b a c h o l ) ,  t e o p h y l l i n e , 
dimethylsulfoxide (DMSO) and ethyl ether were purchased 
from Sigma-Aldrich Co. (St. Louis, MO, USA). All other 
reagents were of analytical grade from local sources. 
Stock solutions of extracts were made using distilled 
water and DMSO and freshly prepared at the same day of 
experimentation.
2.2. Plant material
  Plant species were selected using an ethnomedical 
criterion[6] and were collected and identified by Dr. Patricia 
Castillo España of the Center for Research in Biotechnology, 
UAEM. A sample of each specimen was deposited in 
the HUMO-herbarium of the Center for Research and 
Environmental Studies “Sierra de Huautla”(CEAMISH) of 
Morelos State University. Details of the collection, traditional 
uses,  and voucher number of each species, among others, 
are mentioned in Table 1.
2.3. Extraction of plant material
  The air-dried plant material was ground into powder. 
Crude extracts were prepared by successive room 
temperature-maceration of 30 g of dried plant material in 
600 mL of hexane, dichloromethane and methanol for 72 h, 
respectively. After filtration, extracts were concentrated in 
vacuo at 45 曟. Finally, a yield was obtained for each extract. 
To carry out the experiments, all extracts were dissolved in a 
mixture of dimethylsulfoxide:water (50:50, v:v).
2.4. Pharmacological evaluations
2.4.1. Rats
  Healthy male Wistar rats (250-300 g) were used and 
maintained under standard laboratory conditions with 
free access to food and water. All animal procedures were 
conducted in accordance with our Federal Regulations for 
Animal Experimentation and Care (SAGARPA, NOM-062-
ZOO-1999, Mexico) and approved by the Institutional Animal 
Care and Use Committee based on US National Institute of 
Health publication (No. 85-23, revised 1985). All experiments 
were carried out using six animals per group. Animals used 
were euthanized by cervical dislocation.
2.4.2. Rat trachea ring test
  Previous protocol was used[7]. The trachea was dissected, 
cleaned out of connective tissue and mucus, and 
immediately cut into 4-5 mm long rings. Then, tissue 
segments were mounted in stainless steel hooks, under 
optimal tension of 2 g, in 10 mL organ baths containing 
warmed (37 曟) and oxygenated (O2/CO2, 95:5, v:v) Krebs 
solution (118.0 mmol/L NaCl, 4.7 mmol/L KCl, 2.5 mmol/L 
CaCl2, 1.2 mmol/L MgSO4, 1.2 mmol/L KH2PO4, 25.0 mmol/L 
NaHCO3, 0.026 mmol/L EDTA, and 11.1 mmol/L glucose, pH 
7.4). Changes in tension were recorded by Grass-FT03 force 
transducers (Astromed, West Warwick, RI, USA) connected 
to a MP100 analyzer (BIOPAC Instruments, Santa Barbara, 
CA, USA) as previously described[7]. After equilibration, 
rings were contracted by 1 毺mol/L carbachol and washed 
every 40 min for 2 h. After contraction with carbachol, 
the test samples (organic extracts, vehicle and positive 
control) were added to the bath in a volume of 100 毺L; then 
cumulative concentration-response curves were obtained 
for each ring (3.03-1 000.00 毺g/mL). The relaxant effect of 
extracts and positive control (theophylline, an inhibitor of 
phosphodiesterase, 1.67-550.00 毺mol/L) were determined 
by comparing the muscular tone of the contraction before 
and after addition of the test materials. Muscular tone was 
calculated from the tracings, using Acknowledge software 
(BIOPAC
®
).
2.5. Data analysis
  The experimental results are expressed as mean of six 
experiments ± standard error of mean (SEM). Concentration-
response curves were plotted and experimental data of 
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the concentration-response curves were adjusted by the 
nonlinear, curve-fitting program MicrocalTM origin 8.0 
(Microcal Software Inc., USA). Significance was evaluated 
using the ANOVA[8]. Values of P<0.05 imply significance of 
the pharmacological effects in the experiments.
3. Results
  The plant material was subjected to extraction process by 
maceration, and details of their yields are shown in Table 
2. A total of 15 extracts were evaluated (three for each 
species). All test samples showed significant relaxant effect 
in a concentration-dependent manner on the contractions 
induced by 1 毺mol/L carbachol, with exception of extracts 
from C. morelosana (Table 2). Active extracts were less 
potent than theophylline [phosphodiesterase inhibitor, EC50: 
(28.79±0.82) 毺g/mL] used as positive control. Concentration-
response curves revealed that the extracts with more 
significant effects were dichloromethanic extracts of T. 
mexicana [Emax: (103.03±3.32)% and EC50: (159.39±3.72) 毺g/mL] 
and C. vitifolium [Emax: (106.58±2.42)%; EC50: (219.54±7.61) 
毺g/mL] (Figure 1). Finally, hexanic and dichloromethanic 
extracts from A. mexicana were fully effective but less potent 
than T. mexicana and C. vitifolium (Figure 2).
Table 1
Detailed information about plant species screened.
Plant name Family Common name Voucher number Traditional uses Place of collection
A .  m e x i c a n a  s u b s p . 
xolocotziiana Bye, Lin & 
Ram.
Lamiaceae Toronjil 26336 A n x i e t y , s t r e s s , 
antihypertensive,  heart 
disease, antispasmodic, 
stomachache, vomit, kidney 
inflammation, asthma
Felipe Neri, Morelos State
C. vitifolium (Willd) Bixaceae Pánicua 14628 Antihypertensive, diabetes, 
hepatobiliary disorders
Sierra de Huatla, Morelos 
State
C. morelosana Standley Boraginaceae Anacahuite Pending Respiratory diseases Amatlán, Morelos State
L. caulescens (Ortega) Epling Lamiaceae Bretónica, Brenilla 20386 Kidney diseases, diarrhea, 
vomit, diabetes
Amatlán, Morelos State
T. mexicana (DC.) G. Don Magnoliaceae Yolloxóchitl 1986-012 A Anxiety, sleeplessness, heart 
disease, stress
Jalapa, Veracruz
Figure 1. Concentration-response curves of the relaxant effect of organic extracts on trachea rings pre-contracted with 1 毺mol/L carbachol. 
All results are expressed as the mean±SEM of six experiments (*P<0.05).
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Figure 2. Concentration-response curves of the relaxant effect of the 
most potent organic extracts on trachea rings pre-contracted with 1 
毺mol/L carbachol.
All results are expressed as the mean±SEM of six experiments 
(*P<0.05). HE: Hexane extract; DE: Dichloromethane extract; ME: 
Methanol extract.
4. Discussion
  Medicinal plants A. mexicana, C. vitifolium, C. morelosana, 
L. caulescens and T. mexicana are used in Mexican 
traditional medicine for the treatment of several diseases[6]. 
These plants were selected based on ethnomedical 
criterion[6] and previous reports related with relaxation of 
several smooth muscle tissues[9-15], with exception of C. 
morelosana which is used as an anti-asthmatic agent and 
related respiratory diseases in traditional medicine. Current 
strategies for anti-asthmatic drug development include 
anti-inflammatory and/or bronchodilator drugs. Thus, we 
decided to explore the direct airway relaxant effects of 
hexanic, dichloromethanic and methanolic extracts from 
these selected plants using carbachol-precontracted rat 
tracheal rings, an emergent model related to the widely used 
guinea-pig tracheal model[16].
  In this framework, the extracts were obtained by 
maceration at room temperature and, as we expected, the 
methanolic extracts were those that showed higher yields 
in the extraction process for all plant species, because 
the metabolic content of medicinal plants are mainly 
compounds with medium to high polarity[17]. All extracts 
evaluated showed significant relaxant effect in the range 
of concentrations used, with exception of extracts of C. 
morelosana. However, we cannot discard the anti-asthmatic 
properties of C. morelosana, since this species may act 
through modulating the inflammatory process in asthmatic 
episodes[18], modulating airway hyperresponsiveness and 
hypersensitivity development as a result of asthmatics’ 
status, or inhibiting inflammatory mediator release[19]. 
It is important to mention that C. morelosana is a plant 
species that has been traditionally used for the treatment 
of respiratory diseases and/or asthma, and it is necessary 
to accomplish other pharmacological tests to confirm its 
traditional use in the population, such as the evaluation of 
the asthmatic effect in mice sensitized with ovalbumin[4]. On 
the other hand, extracts from L. caulescens showed moderated 
relaxant effect being hexane extract of L. caulescens the most 
active extract from this plant. Last suggest that previous 
isolated low polarity bioactive compounds from L. caulescens 
may be responsible for the tracheal relaxant effect such as ursolic 
and oleanolic acids, spathulenol, 9毩,13毩-epidioxyabiet-
8(14)-en-18-oic acid methyl ester, dehydroabietic acid, 
and 9毬-hydroxydehydroabietyl alcohol which showed 
relaxant effect on various smooth muscle tissue[9,20]. On 
the other hand, C. vitifolium, A. mexicana and T. mexicana 
are used in traditional Mexican medicine for the treatment 
of cardiovascular diseases. These species were the most 
Table 2
Extraction yield and relaxant effect of plant extracts on rat tracheal rings pre-contracted with carbachol 1 毺mol/L.
Plant name Extract Extraction yield (%) Emax (%) EC50 (毺g/mL)
Positive control Theophylline 106.85±0.89   28.79±0.82
A. mexicana Hexane 1.68 100.16±1.71 219.00±7.40
Dichloromethane 2.15   97.78±3.34 320.87±5.72
Methanol 6.38   75.54±6.03 644.44±4.53
C. vitifolium Hexane 0.45   72.71±6.63 507.14±5.30
Dichloromethane 0.49 106.60±2.42 152.83±7.61
Methanol 1.23   61.91±3.03 631.52±3.42
C. morelosana Hexane 2.93   42.46±5.56 ND
Dichloromethane 1.89   35.80±1.54 ND
Methanol 9.59   29.07±1.71 ND
L. caulescens Hexane 0.81   85.51±1.42 516.69±3.72
Dichloromethane 0.70   59.81±4.39 801.23±4.53
Methanol 2.51   51.67±5.03 ND
T. mexicana Hexane 4.00   97.45±1.04 477.28±5.19
Dichloromethane 6.50 103.03±3.32             159.39±8.7
Methanol 7.00   91.77±5.19 430.71±5.04
Emax and  EC50 indicate efficacy and potency of the extract, respectively. ND: Not determined.
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active tracheal relaxant agents, with the dichloromethanic 
extracts from C. vitifolium and T. mexicana being the 
most active samples, following by the dichloromethanic 
and hexanic extracts from A. mexicana. Previous reports 
showed that C. vitifolium and T. mexicana have significant 
vasorelaxant effect on partially endothelium-dependent 
and concentration-dependent manners on aorta rat rings. 
Flavonoids and triterpenic derivatives were found to be the 
responsible bioactive agents, with NO/cGMP system involved 
as main vasorelaxant mode of action[12-15]. Moreover, there 
is an evidence demonstrating that flavonoids have relaxing 
properties over smooth muscle of the rat and guinea pig 
trachea[21,22]. Finally, T. mexicana has been used since the 
15th century for the treatment of cardiovascular diseases, but 
this species has few pharmacological studies that support 
the traditional uses of the plant[23]. Further phytochemical 
experiments are necessary to isolate the responsible of the 
relaxant effect on tracheal rat rings.
  In conclusion, we have shown that various extracts of T. 
mexicana, C. vitifolium and A. mexicana induced a relaxant 
effect on rat-isolated trachea, which may propose them as 
potential sources for the isolation of anti-asthmatic agent(s).
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